Table 3 Economic evaluation method, analysis and model used to assess the interventions in studies
No | Intervention | Method | Type of analysis | Type of model structure | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alongside clinical study (n = 4) | Model based (n = 31) | CEA (n = 14) | CUA (n = 14) | CBA (n = 1) | CCA (n = 5) | Other (n = 1) | Markov (n = 2) | MMS (n = 4) | DT (n = 14) | DT and other (n = 4) | MM (n = 6) | SM (n = 5) | ||
1 | Antimicrobial stewardship | – | 4 | 2 | 1 | – | 1 | – | – | – | 3 | 1 | - | – |
2 | Awareness generation activities | 1 | 1 | – | 1 | – | 1 | – | - | – | 1 | – | – | 1 |
3 | Government policies and legislations | – | – | – | 1 | – | - | 1 | – | – | – | – | 1 | 1 |
4 | Health care processes and guidelines | 1 | 19 | 11 | 6 | 1 | 2 | – | 1 | 3 | 8 | 2 | 5 | 1 |
5 | Medical technologies | 1 | 1 | – | 1 | – | – | – | – | – | – | – | – | 1 |
6 | Pharmaceutical intervention | 1 | 4 | 1 | 3 | – | 1 | – | – | 1 | 2 | 1 | – | 1 |
7 | Pharmaceutical intervention and health care processes and guidelines | – | 1 | – | 1 | – | – | – | 1 | – | – | – | – | – |